Proof of Principle and Pharmacological Phase 0 Study With Improved Solubility Pazopanib
Latest Information Update: 13 Sep 2017
Price :
$35 *
At a glance
- Drugs Pazopanib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 08 Sep 2017 Status changed from recruiting to completed.
- 04 Apr 2017 Status changed from not yet recruiting to recruiting.
- 05 Jul 2016 New trial record